+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors

Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors

Human Pathology 40(6): 868-871

Deregulation of apoptosis is one of the hallmarks of cancer, and inactivation of cancer cell apoptosis has been reported in many cancers. Caspases, the main executioners during apoptosis and inflammation, have been reported to harbor inactivating mutations in several cancers. The aim of this study was to explore whether CASP1 to 10 and 14 genes that encode caspase 1 to 10 and 14 are somatically mutated in gastrointestinal stromal tumor. We analyzed the entire coding region and all splice sites of all 11 human CASP genes for the detection of somatic mutations in 22 gastrointestinal stromal tumors by a single strand conformation polymorphism assay. We found a recurrent CASP4 mutation (c.1093C>G [p.L365V]) in 4 gastrointestinal stromal tumors, but there were no mutations in the other 10 CASPs. The CASP4 mutation was a missense mutation and was predicted to substitute amino acids in the small protease subunit of caspase 4. Overall, the gastrointestinal stromal tumor tissues harbored a CASP mutation in 18.2% (4/22). Our data indicate that somatic mutation of the CASP4 gene is common in gastrointestinal stromal tumor and suggest a possibility that CASP4 mutation might lead to alteration of apoptotic or inflammatory function and contribute to the pathogenesis of some gastrointestinal stromal tumors.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054514268

Download citation: RISBibTeXText

PMID: 19269008

DOI: 10.1016/j.humpath.2008.11.013

Related references

Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis. Journal of Gastrointestinal and Liver Diseases 22(4): 413-418, 2014

Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples. Revista Espanola de Enfermedades Digestivas 107(2): 72-78, 2016

Underuse of exon mutational analysis for gastrointestinal stromal tumors. Journal of Surgical Research 231: 43-48, 2018

Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors. Oncology Reports 37(3): 1671-1681, 2017

The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting. Journal of Translational Medicine 9: 75, 2011

Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes. Cancer Genomics and Proteomics 10(3): 115-123, 2014

Overcoming Cost Implications of Mutational Analysis in Patients with Gastrointestinal Stromal Tumors: A Pragmatic Approach. Oncology Research and Treatment 39(12): 811-816, 2016

Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies. Cancer Investigation 28(8): 839-848, 2010

Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer 93(4): 269-275, August 25, 2001

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Annals of Diagnostic Pathology 11(1): 27-33, 2007

Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile. Pathology, Research and Practice 210(6): 392-396, 2014

Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes, Chromosomes and Cancer 46(3): 261-276, 2006

Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors. Anticancer Research 30(7): 2705-2715, 2010

Identification of key genes related to high-risk gastrointestinal stromal tumors using bioinformatics analysis. Journal of Cancer Research and Therapeutics 14(Suppl.): S243-S247, 2018

Correlation between mutational types and targeted treatment in gastrointestinal stromal tumors. Zhonghua Bing Li Xue Za Zhi 37(8): 555-558, 2010